ID   BEL-7404-CP.3
AC   CVCL_IP16
SY   BEL7404-CP.3; 7404-CP.3
DR   Wikidata; Q54795975
RX   PubMed=7710928;
CC   Problematic cell line: Contaminated. Parent cell line (BEL-7404) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6568 ! BEL-7404
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
CH   CVCL_IP07 ! BEL-7404-CP1
//
RX   PubMed=7710928; DOI=10.1038/bjc.1995.134; PMCID=PMC2033730;
RA   Shen, Ding-Wu
RA   Akiyama, Shin-ichi
RA   Schoenlein, Patricia V.
RA   Pastan, Ira
RA   Gottesman, Michael Marc
RT   "Characterisation of high-level cisplatin-resistant cell lines
RT   established from a human hepatoma cell line and human KB
RT   adenocarcinoma cells: cross-resistance and protein changes.";
RL   Br. J. Cancer 71:676-683(1995).
//